Foghorn Therapeutics, Inc. (FHTX)
1.90
-0.14
(-6.86%)
USD |
NASDAQ |
Nov 10, 16:00
1.90
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Cash from Operations (Annual) : -86.10M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -86.10M |
| December 31, 2024 | -100.41M |
| December 31, 2023 | -118.11M |
| December 31, 2022 | 193.61M |
| Date | Value |
|---|---|
| December 31, 2021 | -50.25M |
| December 31, 2020 | -31.29M |
| December 31, 2019 | -46.34M |
| December 31, 2018 | -22.65M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anavex Life Sciences Corp. | -39.04M |
| Vaxcyte, Inc. | -655.58M |
| Connect Biopharma Holdings Ltd. | -51.21M |
| Caribou Biosciences, Inc. | -110.99M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |